Skip to content

Prevalence of Amyloidosis in Trauma Patients

Prevalence of Amyloidosis in Trauma Patients Using Red Flags Tool

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06527521
Acronym
APTUR
Enrollment
246
Registered
2024-07-30
Start date
2024-11-13
Completion date
2026-10-31
Last updated
2025-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyloidosis

Keywords

Amyloidosis, Red Flags tool, Traumatology

Brief summary

This study aims to determine the frequency of amyloidosis among patients undergoing trauma surgery.

Interventions

PROCEDURETraumatologic surgery

Patients undergoing trauma surgery

Sponsors

Consorci Sanitari de l'Alt Penedès i Garraf
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Men and women included in the waiting list for scheduled trauma surgery with at least one of the following criteria defined as red flags: Over 65 years old; Possible family history of amyloidosis, Cardiac pathology: aortic stenosis, presence of left ventricular hypertrophy defined as interventricular septal thickness \> 12mm measured by echocardiography, history of previous brady- or tachyarrhythmias including cardiac conduction blocks, history of syncope or presyncope, pro BNP \> 300 in previous blood tests; History of sensory peripheral neuropathy; History of nephropathy without etiological diagnosis; History of liver disease without a clear cause. * Ability to cooperate in the necessary evaluations. * Signed informed consent for inclusion in the study, either by the participant or their legal representative.

Exclusion criteria

\- Participants previously diagnosed with amyloidosis cannot be included in the study.

Design outcomes

Primary

MeasureTime frameDescription
AmyloidosisOne monthProportion of patients undergoing scheduled orthopedic surgery who are diagnosed with amyloidosis.

Countries

Spain

Contacts

Primary ContactLidia Tikhomirova, MD
ltikhomirova@csapg.cat+34 938960025
Backup ContactNoemí Casaponsa
recerca@csapg.cat+34 938960025

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026